These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 194263

  • 1. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA.
    Pharmacol Res Commun; 1977 Jan; 9(1):49-58. PubMed ID: 194263
    [No Abstract] [Full Text] [Related]

  • 2. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A, Schultz J.
    Experientia; 1975 Aug 15; 31(8):883-4. PubMed ID: 169139
    [No Abstract] [Full Text] [Related]

  • 3. The interaction of 4-alkyl derivatives of 2,6,7-trioxa-1-phosphabicyclo [2,2,2] octanes with cyclic adenosine 3',5'-monophosphate phosphodiesterase, and with cyclic adenosine 3',5'-monophosphate binding proteins.
    Coult DB, Wilkinson RG.
    Biochem Pharmacol; 1977 May 01; 26(9):887-9. PubMed ID: 193519
    [No Abstract] [Full Text] [Related]

  • 4. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue.
    Green D, Guy G, Moore JB.
    Life Sci; 1977 Apr 01; 20(7):1157-62. PubMed ID: 191714
    [No Abstract] [Full Text] [Related]

  • 5. Phosphodiesterase 4 isoenzyme inhibitory activity of 3-phenylxanthines and 4-pheny.
    Suzuki H, Sawanishi H, Yamamoto K, Yokogawa K, Miyamoto K.
    Chem Pharm Bull (Tokyo); 2001 Feb 01; 49(2):188-91. PubMed ID: 11217107
    [Abstract] [Full Text] [Related]

  • 6. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
    Bocek RM, Beatty CH.
    Dev Biol; 1976 Feb 01; 48(2):382-91. PubMed ID: 176071
    [No Abstract] [Full Text] [Related]

  • 7. Effects of 1-benzylxanthines on cyclic AMP phosphodiesterase 4 isoenzyme.
    Suzuki H, Sawanishi H, Nomura M, Shimada T, Miyamoto K.
    Biol Pharm Bull; 2006 Jan 01; 29(1):131-4. PubMed ID: 16394525
    [Abstract] [Full Text] [Related]

  • 8. [Adenosine-3',5'-monophosphate phosphodiesterase of the cerebral cortex and the effect of cardiovascular preparations].
    Libinzon RE, Shchekoldina TG, Batolkina OE, Iagniatinskaia AM.
    Vopr Med Khim; 1977 Jan 01; 23(4):526-30. PubMed ID: 200004
    [No Abstract] [Full Text] [Related]

  • 9. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN, Miller JR.
    Methods Enzymol; 1988 Jan 01; 159():489-96. PubMed ID: 2457788
    [No Abstract] [Full Text] [Related]

  • 10. Mesoionic xanthine analogs as inhibitors of cyclic AMP phosphodiesterase.
    Glennon RA, Rogers ME, Bass RG, Ryan SB.
    J Pharm Sci; 1978 Dec 01; 67(12):1762-5. PubMed ID: 214541
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.
    Kramer GL, Garst JE, Mitchel SS, Wells JN.
    Biochemistry; 1977 Jul 26; 16(15):3316-21. PubMed ID: 196632
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition by purine compounds of cyclic GMP-stimulated cyclic AMP phosphodiesterase activity from a particulate fraction of rat striatum.
    Oleshansky MA.
    Life Sci; 1980 Sep 22; 27(12):1089-95. PubMed ID: 6158640
    [No Abstract] [Full Text] [Related]

  • 13. Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
    Francis DL, Roy AC, Collier HO.
    Life Sci; 1975 Jun 15; 16(12):1901-6. PubMed ID: 168452
    [No Abstract] [Full Text] [Related]

  • 14. Influence of tricyclic antidepressants on the adenylate cyclase-phosphodiesterase system in the rat cortex.
    Palmer GC.
    Neuropharmacology; 1976 Jan 15; 15(1):1-7. PubMed ID: 176608
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH, Brenner MJ, Muschek LD.
    Recent Adv Stud Cardiac Struct Metab; 1973 Jan 15; 3():261-73. PubMed ID: 4377599
    [No Abstract] [Full Text] [Related]

  • 16. Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines.
    Sawanishi H, Suzuki H, Yamamoto S, Waki Y, Kasugai S, Ohya K, Suzuki N, Miyamoto K, Takagi K.
    J Med Chem; 1997 Sep 26; 40(20):3248-53. PubMed ID: 9379444
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
    Nagata K, Ogawa T, Omosu M, Fujimoto K, Hayashi S.
    Arzneimittelforschung; 1985 Sep 26; 35(7):1034-6. PubMed ID: 2996562
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of a high molecular weight cyclic 3',5'-nucleotide phosphodiesterase isolated from rat liver.
    Rhoads AR, Olowofoyeku AK, West WL, Morris HP.
    Biochem Pharmacol; 1976 Jan 26; 25(1):97-9. PubMed ID: 175802
    [No Abstract] [Full Text] [Related]

  • 19. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
    Stefanovich V.
    Neurochem Res; 1979 Dec 26; 4(6):681-7. PubMed ID: 232543
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and cyclic AMP phosphodiesterase 4 isoenzyme inhibitory activity of heterocycle condensed purines.
    Suzuki H, Yamamoto M, Shimura S, Miyamoto K, Yamamoto K, Sawanishi H.
    Chem Pharm Bull (Tokyo); 2002 Sep 26; 50(9):1163-8. PubMed ID: 12237530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.